Source: Shutterstock/Nazarenko LLC

A new weapon against antibiotic resistance

Programming a hunter/killer toxin

When the first antibiotics were discovered in the early 20th century, the rate of death from infectious diseases fell dramatically. But the emergence of multidrug-resistant bacteria as a result of antibiotic misuse is raising fears that by 2050, these same diseases will once again become the leading cause of death worldwide.

In a bid to boost the arsenal available to tackle this threat, scientists from the Institut Pasteur, the CNRS and the Universidad Politécnica de Madrid successfully programmed a bacterial genetic structure to make it capable of specifically killing multiple antibiotic-resistant bacteria without also destroying bacteria that are beneficial to the body. Unlike other approaches under development, this novel tool is associated with a minimal rate of emergence of new resistance. The results were published in the journal Nature Biotechnology.

One of the challenges of this method is how to control the sheer power of these toxins

Didier Mazel

When an antibiotic treatment is used, the therapeutic molecules attack all the bacteria in the microbiota. This non-targeted destruction leads to dysbiosis, in other words a disruption in the balance of the bacterial ecosystem that can result in the emergence of opportunistic bacteria or resistance to the antibiotic used. The harmful impact of dysbiosis can be prevented by developing highly specific antimicrobial strategies. For example, the CRISPR-Cas9 tool can be used to target the resistance genes in pathogenic bacteria, but the rate of escape associated with the technique (when the pathogen manages to escape the various defense mechanisms employed by the infected organism) is relatively high.

In this study, a scientific team directed by Didier Mazel, Professor at the Institut Pasteur, developed an alternative strategy based on the specific expression of extremely powerful toxins delivered by conjugation. Conjugation is a process used by bacteria to exchange genes via plasmids, DNA molecules that are specific of bacterial genomes. In this novel strategy, the gene encoding the toxin is inside the plasmid. "The use of toxins from the type II toxin-antitoxin system seemed like a good idea because it appears that bacteria do not develop resistance to this arsenal", said Didier Mazel, lead author of the paper and head of the Bacterial genome plasticity unit at the Institut Pasteur. "But one of the challenges of this method is how to control the sheer power of these toxins. We did this by separating their genes into two fragments, to make sure that they would only be effective if the two parts could be recombined."

Observing the culture of a bacterial strain. Each disk is impregnated with a...
Observing the culture of a bacterial strain. Each disk is impregnated with a different antibiotic. The clear circles around the disks indicate that the bacteria have been killed by the antibiotic and that they are therefore not resistant to it.

© Institut Pasteur

The scientists verified the specific nature of this toxin in Vibrio cholerae, a marine bacterium whose natural hosts are certain fish and shellfish. "We firstly wanted to activate toxin expression in Vibrio cholerae, using a promoter (a DNA region required for transcription) specifically recognized by this bacterium which expresses and activates the toxin complex," continues Didier Mazel. They then refined this "weapon" further so that the toxin would only be able to target antibiotic-resistant strains of Vibrio cholerae. This involved creating a genetic module expressing a highly specific toxin inhibitor, an antitoxin, which is no longer produced when the bacterium contains resistance genes. By combining these two procedures, they developed a genetic structure whose efficacy was verified in vivo in the complex natural communities of bacteria in the zebrafish and Artemia microbiotas. "The level of escape for this alternative strategy is very low. It can be easily adapted for the specific destruction of several other pathogens. We now need to improve the process of gene delivery by the plasmid," concludes Didier Mazel.

A patent application has been filed by the Institut Pasteur and the French National Center for Scientific Research (CNRS) for the genetic tool designed by Didier Mazel and his team and for its applications. This European patent application (EP18306780) was filed on December 20, 2018 under the name Intein mediated protein splicing system for controlled expression of proteins – Use in the expression of toxins in target cells.


Source: Institut Pasteur

16.04.2019

Read all latest stories

Related articles

Photo

Aging research

Finding Nemo's secret of longevity

It is the Methusalem among fishkind: The colorful Clownfish lives longer than 20 years in the Aquarium. Researchers of the Scuola Normale Superiore in Pisa, Italy, in collaboration with the Leibniz…

Photo

Against rebound

Pancreatic cancer: Genome-wide analysis reveals new strategies

For some cancers, initial treatment with chemotherapy brings positive, but only temporary, results: tumors shrink, but then rebound as the cancer becomes drug-resistant. This pattern of…

Photo

Alarming results

Antibiotic resistance spreads faster than previously thought

By studying fish raised in aquaculture, researchers from the Helmholtz Zentrum München, the University of Copenhagen and the University of Campinas in Brazil have shed new light on the mechanisms by…

Related products

Eppendorf - Mastercycler nexus X2

Research use only (RUO)

Eppendorf - Mastercycler nexus X2

Eppendorf AG
Agena Bioscience - MassARRAY Colon Panel

Amplification/Detection

Agena Bioscience - MassARRAY Colon Panel

Agena Bioscience GmbH
Eppendorf - BioSpectrometer fluroescence

Research use only (RUO)

Eppendorf - BioSpectrometer fluroescence

Eppendorf AG
Eppendorf - μCuvette G1.0

Research use only (RUO)

Eppendorf - μCuvette G1.0

Eppendorf AG
Orion Diagnostica Oy - Orion GenRead

Amplification

Orion Diagnostica Oy - Orion GenRead

Orion Diagnostics Oy